Target lesion failure with BRS? good old DES to the rescue

Michela Faggioni; Roxana Mehran

doi:10.1002/ccd.26536

Target lesion failure with BRS? good old DES to the rescue

Catheter Cardiovasc Interv. 2016 Apr;87(5):837-8. doi: 10.1002/ccd.26536.

Authors

Michela Faggioni^{1

2}, Roxana Mehran¹

Affiliations

¹ The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
² Cardiothoracic Department, Division of Cardiology, University Hospital of Pisa, Italy.

PMID: 27085024
DOI: 10.1002/ccd.26536

Abstract

Target lesion revascularization (TLR) for BRS failure is burdened with a high rate of adverse events. DES implantation appears to be the safest treatment option following BRS failure. A real world observational study with a minimum of 2-year follow-up would be required to investigate the long-term clinical outcomes in patients with a BRS failure and to assess the best treatment option in case of TLR.

Publication types

Editorial
Comment

MeSH terms

Coronary Angiography*
Drug-Eluting Stents*
Follow-Up Studies
Humans
Treatment Outcome